
<div id="container" class="bg4"> 
  
  <!--menu top-->
   <div id="menu_top"></div>
  <!--end menu top--> 
  
  <!--elements-->
  <div class="btn_plus" rel="presentation/assets/P03_T06_S01/popup.html#1" parent=".P03_T06_S01"></div>
  <div class="btn_lib"></div>
  <div class="btn_ref"></div>
  <!--end elements--> 
  
  
  <div id="main_container">
    <div class="title tradegothicltstd_bd2">
      <i18n id="v21_title"></i18n>
    </div>
    <div class="line_board"></div>
    <div class="title_top tradegothicltstd_bd2 white">
      <i18n id="v21_title_top">Plasmaaustausch/Plasmainfusion
</i18n>
    </div>
    <div class="board">
      <div class="title_board tradegothicltstd_bd2 white">
        <i18n id="v21_title_board">Vergleichbare Morbidit채t und Mortalit채t unabh채ngig von PE/PI<sup>(18)</sup></i18n>
      </div>
      <div class="txt_left tradegothicltstd_bd2">
        <i18n id="v21_txt_left">% Patienten, die verstorben oder<br>terminal niereninsuffizient sind oder  eine <br>
        andere TMA-Manifestation aufwiesen in %*</i18n>
      </div>
      <div class="txt_chart1_2 tradegothicltstd_bd2">
        <i18n id="v21_txt_1a">Nach 1 Monat</i18n>
      </div>
      <div class="txt_chart3_4 tradegothicltstd_bd2">
        <i18n id="v21_text_4">Nach 6 Monaten </i18n>
      </div>
      
      <div class="chart">
        <div class="txt1 tradegothicltstd_bd2 white">
          <i18n id="v21_txt1"></i18n>
        </div>
        <div class="txt2 tradegothicltstd_bd2 white">
          <i18n id="v21_txt2">22%</i18n>
        </div>
        <div class="txt4 tradegothicltstd_bd2 white"><i18n id="v21_txt3">22%</i18n></div>
        <div class="txt5 tradegothicltstd_bd2 white"><i18n id="v21_txt4">57%</i18n></div>
        <div class="txt6 tradegothicltstd_bd2 white"><i18n id="v21_txt5">61%</i18n></div>
      </div>
      <div class="drop"></div>
      <div class="mark"></div>
      <div class="bullet_a"></div>
      <div class="bullet_b"></div>
      <div class="txt_bullet1 tradegothic_re">
        <i18n id="v21_txt_bullet1">mit PE/PI (n=23)</i18n>
      </div>
      <div class="txt_bullet2 tradegothic_re">
        <i18n id="v21_txt_bullet2">ohne PE/PI (n=23)</i18n>
      </div>
      <div class="tradegothic_re bot_board_text"><i18n id="v21_bot_board_text">*TMA Manifestionen waren Hb-Konzentrationen &lt;10 g/dL mit Fragmentozyten und/oder Thrombozyten &lt;150 G/L, Serum Kreatinin > 97. Perzentile f체r das entsprechende Alter und/oder Proteinurie >1+.<sup>(18)</sup></i18n></div>
    </div>
    <div class="number tradegothicltstd grey_dark">
      <i18n id="v21_number">60</i18n>
    </div>
    <div class="number1 tradegothicltstd grey_dark">
      <i18n id="v21_number1">80</i18n>
    </div>
    <div class="number2 tradegothicltstd grey_dark">
      <i18n id="v21_number2"></i18n>
    </div>
    <div class="number4 tradegothicltstd grey_dark">
      <i18n id="v21_number4"></i18n>
    </div>
    <div class="number6 tradegothicltstd grey_dark">
      <i18n id="v21_number6">0</i18n>
    </div>
  </div>
  <!--End #main_container -->
  
  <div class="claim_2line">
    <i18n id="v21_claim_1line">Es existieren keine kontrollierten Studien, die die Sicherheit und
Wirksamkeit von Plasmaaustausch/Plasmainfusion (PE/PI) bei aHUS-Patienten belegen<sup>(5)</sup></small></i18n>
  </div>
  <!--end .claim_1line-->
  
  <div class="lg_alexion"></div>
  
  <!--Ref-->
  <div class="ref_warpper bg_ref">
    <h1>
      <i18n id="v21_refernces">REFERENZEN</i18n>
    </h1>
    <div class="inner_wapper">
      <div class="scroller">
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_5">5.</i18n>
          </span>
          <i18n id="v21_content_num5">Loirat C, Garnier A, Sellier-Leclerc AL, Kwon T. Semin Thromb Hemost. 2010;36:673-681</i18n>
        </div>
        <!--end Ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_8">18.</i18n>
          </span>
          <i18n id="v21_content_num8">Sellier-Leclerc AL, Fremeaux-Bacchi V, Dragon-Durey MA et al. French Society of Pediatric  Nephrology. J  Am  Soc  Nephrol. 2007;18:2392-2400</i18n>
        </div>
        <!--end Ref-->
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_28">41.</i18n>
          </span>
          <i18n id="v21_content_num28">Nyugen L, Terrell DR, Duvall D, Vesely SK, George JN. Transfusion. 2009;49:392-394</i18n>
        </div>
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_29">42.</i18n>
          </span>
          <i18n id="v21_content_num29">Rizvi MA, Vesely SK, George JN et al. Transfusion. 2000;40:896-901</i18n>
        </div>
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_30">43.</i18n>
          </span>
          <i18n id="v21_content_num30">McMinn JR Jr, Thomas IA, Terrell DR, Duvall D, Vesely SK, George JN. Transfusion. 2003;43:415-416</i18n>
        </div>
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_31">44.</i18n>
          </span>
          <i18n id="v21_content_num31">Howard MA, Williams LA, Terrell DR, Duvall D, Vesely SK, George JN. Transfusion. 2006;46:154-156</i18n>
        </div>
        <div class="ref"> <span class="ref_number">
          <i18n id="v21_num_53">45.</i18n>
          </span>
          <i18n id="v21_content_num53">Zuber J, Fakhouri F, Roumenina LT, et al; on behalf of the French Study Group for aHUS/C3G. Nat Rev Nephrol.2012;8:643-657</i18n>
        </div>
        <div class="ref">
          <i18n id="v21_content_num54">  </i18n>
        </div>
        
      </div>
      <!--end .scroller--> 
    </div>
    <!--end .inner_wapper-->
    <div class="close"></div>
  </div>
  <!--end ref--> 
  
</div>
<% 
slide.load('css/main.css',
		   'javascript/main.js'); 
%> 